HIF-PHD inhibitors in renal anemia | Update on phase 3 clinical trials
HIF-PHD inhibitors in renal anemia | Update on phase 3 clinical trials
Anemia of Chronic Kidney Disease: Will New Agents Deliver on Their Promise?
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
A new insight into the treatment of renal anemia with HIF stabilizer | Renal Replacement Therapy | Full Text
Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis - ScienceDirect
Hif ph inhibitors for anemia in ckd | PPT
A new insight into the treatment of renal anemia with HIF stabilizer | Renal Replacement Therapy | Full Text
The HIF System Response to ESA Therapy in CKD‐Anemia | IntechOpen
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects | Clinical and Experimental Nephrology
HIF prolyl-hydroxylase inhibitor - Wikipedia
Stabilization of hypoxia-inducible factor ameliorates glomerular injury sensitization after tubulointerstitial injury - ScienceDirect
Ap romising novelt herapeutic approach for the treatment of anemia:... | Download Scientific Diagram
Frontiers | Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases
Cureus | An Overview of Safety and Efficacy Between Hypoxia-Inducible Factor-Prolyl-Hydroxylase Inhibitors and Erythropoietin-Stimulating Agents in Treating Anemia in Chronic Kidney Disease Patients | Article
PCC-Funded Researcher's work on HIF stabilizers wins TIAFT Young Scientist Award for Best Oral Presentation - PCC - Global Anti-Doping Research Grants for Scientists and Researchers
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
HIF PHI Trials in CKD non-dialysis and dialysis: What do the data really show?
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease pat
a, b HIF activity under normoxic/ hypoxic conditions and HIF-PHI... | Download Scientific Diagram
Edgar V. Lerma 🇵🇭 on X: "AGARWAL: HIF stabilizers - safety concerns #Nephpearls #NKFClinicals https://t.co/v82n2tAusp" / X
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
HIF-1 as a target for drug development | Nature Reviews Drug Discovery
